Gov’t expands 1+ drug approval mechanism

Vaccines and advanced therapy products can now be registered in HK.

The Hong Kong government said the ‘1+’ drug approval mechanism will be expanded to cover all new chemical entities starting next month, aiming to elevate healthcare standards.

Secretary for Health Lo Chung-mau said that it will enable any new chemical entity, inclusing vaccines and advanced therapy products, to be registered in Hong Kong, giving patients more drug choices at lower costs.

“It will also promote drug research and development in the whole Greater Bay Area (GBA),” Chung-Mau said.

The secretary also said that through a "connect" measure, drugs and medical devices registered in Hong Kong but are not yet approved in Mainland China can be used by GBA healthcare institutions.

“This is advantageous for pharmaceutical companies as these drugs and devices have a ‘green channel’ for use of the 68 million residents in GBA,” Chung-Mau added.

Also Read

HK records 35,373 new cancer cases in 2022

Braillic’s AR tech helps brain surgeons see through the walls

Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

I want to download the media kit